[1] HOOI J K Y,LAI W Y,NG W K,et al.Global prevalence of helicobacter pylori infection:systematic review and meta-analysis[J].Gastroenterology,2017,153(2):420-429.
[2] MARSHALL B J,WARREN J R.Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration[J].Lancet,1984,1(8390):1311-1315.
[3] WAN Z,SONG L,HU L,et al.Helicobacter pylori infection is associated with diabetes among Chinese adults[J].J Diabetes Investig,2020,11(1):199-205.
[4] DE LUIS D A,LAHERA M,CANTÓN R,et al.Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients[J].Diabetes Care,1998,21(7):1129-1132.
[5] HAMED S A,AMINE N F,GALAL G M,et al.Vascular risks and complications in diabetes mellitus:the role of helicobacter pylori infection[J].J Stroke Cerebrovasc Dis,2008,17(2):86-94.
[6] AL QARNI A A,JOATAR F E,DAS N,et al.Association of plasma ghrelin levels with insulin resistance in type 2 diabetes mellitus among Saudi Subjects[J].Endocrinol Metab(Seoul),2017,32(2):230-240.
[7] GULCELIK N E,KAYA E,DEMIRBAS B,et al.Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy[J].J Endocrinol Invest,2005,28(3):214-217.
[8] ZIMMET P,ALBERTI K G,MAGLIANO D J,et al.Diabetes mellitus statistics on prevalence and mortality:facts and fallacies[J].Nat Rev Endocrinol,2016,12(10):616-622.
[9] ZHOU X,LIU W,GU M,et al.Helicobacter pylori infection causes hepatic insulin resistance by the c-Jun/miR-203/SOCS3 signaling pathway[J].J Gastroenterol,2015,50(10):1027-1040.
[10] OLDENBURG B,DIEPERSLOOT R J,HOEKSTRA J B.High seroprevalence of Helicobacter pylori in diabetes mellitus patients[J].Dig Dis Sci,1996,41(3):458-461.
[11] BENER A,AǦAN A F,AL-HAMAQ A,et al.Prevalence of helicobacter pylori infection among type 2 diabetes mellitus[J].Adv Biomed Res,2020,9:27.
[12] BARADARAN A,DEHGHANBANADAKI H,NADERPOUR S,et al.The association between Helicobacter pylori and obesity:a systematic review and meta-analysis of case-control studies[J].Clin Diabetes Endocrinol,2021,7(1):15.
[13] LI J Z,LI J Y,WU T F,et al.Helicobacter pylori infection is associated with type 2 diabetes,not type 1 diabetes:an updated meta-analysis[J].Gastroenterol Res Pract,2017,2017:5715403.
[14] HOSSEININA S A B NODOUSHAN S A,NABAVI A.The interaction of helicobacter pylori infection and type 2 diabetes mellitus[J].Adv Biomed Res,2019,8:15.
[15] LU J,HE J,LI M,et al.Predictive value of fasting glucose,postload glucose,and hemoglobin a1c on risk of diabetes and complications in Chinese adults[J].Diabetes Care,2019,42(8):1539-1548.
[16] CHAUDHARY A,ANSARI A.Role of helicobacter pylori infection on diabetic and lipid profile in pre-diabetic patients[J].J Clin of Diagn Res,2021,15(3):OC18-OC21.
[17] JEON C Y,HAAN M N,CHENG C,et al.Helicobacter pylori infection is associated with an increased rate of diabetes[J].Diabetes Care,2012,35(3):520-525.
[18] 王少真,史亚男,赵静,等.幽门螺杆菌对2型糖尿病患者血糖波动的影响[J].中华医学杂志,2009,89(14):958-961.
[19] HORIKAWA C,KODAMA S,FUJIHARA K,et al.Association of helicobacter pylori infection with glycemic control in patients with diabetes:a meta-analysis[J].J Diabetes Res,2014,2014:250620.
[20] CHENG K P,YANG Y J,HUNG H C,et al.Helicobacter pylori eradication improves glycemic control in type 2 diabetes patients with asymptomatic active Helicobacter pylori infection[J].J Diabetes Investig,2019,10(4):1092-1101.
[21] MALUF S,SALGADO J V,CYSNE D N,et al.Increased glycated hemoglobin levels in patients with helicobacter pylori infection are associated with the grading of chronic gastritis[J].Front Immunol,2020,11:2121.
[22] SONG X,CAI C,JIN Q,et al.The efficacy of helicobacter pylori eradication in diabetics and its effect on glycemic control:a systematic review and meta-analysis[J].Helicobacter,2021,26(2):e12781.
[23] BONFIGLI A R,BOEMI M,FESTA R,et al.Randomized,double-blind,placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients[J].Nutr Metab Cardiovasc Dis,2016,26(10):893-898.
[24] UPALA S,SANGUANKEO A,SALEEM S A,et al.Effects of helicobacter pylori eradication on insulin resistance and metabolic parameters:a systematic review and meta-analysis[J].Eur J Gastroenterol Hepatol,2017,29(2):153-159.
[25] VAFAEIMANESH J,RAJABZADEH R,AHMADI A,et al.Effect of helicobacter pylori eradication on glycaemia control in patients with type 2 diabetes mellitus and comparison of two therapeutic regimens[J].Arab J Gastroenterol,2013,14(2):55-58.
[26] NEWMAN J D,SCHWARTZBARD A Z,WEINTRAUB H S,et al.Primary prevention of cardiovascular disease in diabetes mellitus[J].J Am Coll Cardiol,2017,70(7):883-893.
[27] LEE S J,AVOLIO A,SEO D C,et al.Relationship between brachial-ankle pulse wave velocity and incident hypertension according to 2017 ACC/AHA high blood pressure guidelines[J].J Am Heart Assoc,2019,8(16):e013019.
[28] YANG Y F,LI Y,LIU J H,et al.Relation of helicobacter pylori infection to peripheral arterial stiffness and 10-year cardiovascular risk in subjects with diabetes mellitus[J].Diab Vasc Dis Res,2020,17(5):1479164120953626.
[29] KOWALSKI M.Helicobacter pylori(H.pylori) infection in coronary artery disease:influence of H.pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty.The detection of H.pylori specific DNA in human coronary atherosclerotic plaque[J].J Physiol Pharmacol,2001,52(1 Suppl 1):3-31.
[30] KIM Y I,KIM Y A,KIM H J,et al.Effect of helicobacter pylori treatment on the long-term mortality in patients with type 2 diabetes[J].Korean J Intern Med,2021,36(3):584-595.
[31] LIN S Y,LIN C L,LIU J H,et al.Association between helicobacter pylori infection and the subsequent risk of end-stage renal disease:a nationwide population-based cohort study[J].Int J Clin Pract,2015,69(5):604-610.
[32] CHUNG G E,HEO N J,PARK M J,et al.Helicobacter pylori seropositivity in diabetic patients is associated with microalbuminuria[J].World J Gastroenterol,2013,19(1):97-102.
[33] YANIK S,DOG∨AN Z,SARIKAYA M,et al.Helicobacter pylori eradication reduces microalbuminuria in type-2 diabetic patients:a prospective study[J].Acta Gastroenterol Belg,2014,77(2):235-239.
[34] SHI Y,DUAN J Y,LIU D W,et al.Helicobacter pylori infection is associated with occurrence of proteinuria in type 2 diabetes patients:a systemic review and meta-analysis[J].Chin Med J(Engl),2018,131(22):2734-2740.
[35] AKEEL M,SHEHATA A,ELHAFEY A,et al.Helicobacter pylori vacA,cagA and iceA genotypes in dyspeptic patients from southwestern region,Saudi Arabia:distribution and association with clinical outcomes and histopathological changes[J].BMC Gastroenterol,2019,19(1):16.
[36] KAYAR Y,PAMUKÇU Ö,EROG∨LU H,et al.Relationship between helicobacter pylori infections in diabetic patients and inflammations,metabolic syndrome,and complications[J].Int J Chronic Dis,2015,2015:290128.
[37] WANG F,FU Y,LV Z.Association of helicobacter pylori infection with diabetic complications:a meta-analysis[J].Endocr Res,2014,39(1):7-12.
[38] DEMIR M,GOKTURK H S,OZTURK N A,et al.Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications[J].Dig Dis Sci,2008,53(10):2646-2649.
[39] GENTILE S,TURCO S,OLIVIERO B,et al.The role of autonomic neuropathy as a risk factor of helicobacter pylori infection in dyspeptic patients with type 2 diabetes mellitus[J].Diabetes Res Clin Pract,1998,42(1):41-48.
[40] ZHANG X Y,ZHANG P Y,Aboul-Soud M A M,et al.From inflammation to gastric cancer:role of helicobacter pylori[J].Oncol letters,2017,13(2):543-548.
[41] FURMAN D,CAMPISI J,VERDIN E,et al.Chronic inflammation in the etiology of disease across the life span[J].Nat Med,2019,25(12):1822-1832.
[42] ELIMAM H,ABDULLA A M,TAHA I M.Inflammatory markers and control of type 2 diabetes mellitus[J].Diabetes Metab Syndr,2019,13(1):800-804.
[43] LUAN Y Y,YAO Y M.The clinical significance and potential role of c-reactive protein in chronic inflammatory and neurodegenerative diseases[J].Front Immunol,2018,9:1302.
[44] 代敏涛,吴太宇,张宇,等.胃炎患者幽门螺杆菌感染与血清学指标及病理的相关性[J].中华医院感染学杂志,2019,29(24):3719-3723.
[45] JACKSON L,BRITTON J,LEWIS S A,et al.A population-based epidemiologic study of helicobacter pylori infection and its association with systemic inflammation[J].Helicobacter,2009,14(5):108-113.
[46] GEN R,DEMIR M,ATASEVEN H.Effect of helicobacter pylori eradication on insulin resistance,serum lipids and low-grade inflammation[J].South Med J,2010,103(3):190-196.
[47] AKBARI M,HASSAN-ZADEH V.IL-6 signalling pathways and the development of type 2 diabetes[J].Inflammopharmacology,2018,26(3):685-698.
[48] ABDEL-RAZIK A,MOUSA N,SHABANA W,et al.Helicobacter pylori and non-alcoholic fatty liver disease:a new enigma?[J].Helicobacter,2018,23(6):e12537.
[49] AZAMI M,BARADARAN H R,DEHGHANBANADAKI H,et al.Association of helicobacter pylori infection with the risk of metabolic syndrome and insulin resistance:an updated systematic review and meta-analysis[J].Diabetol Metab Syndr,2021,13(1):145.
[50] FRANCESCHI F,ANNALISA T,TERESA D R,et al.Role of helicobacter pylori infection on nutrition and metabolism[J].World J Gastroenterol,2014,20(36):12809-12817.
[51] LEE N J,QI Y,ENRIQUEZ R F,et al.Energy partitioning between fat and bone mass is controlled via a hypothalamic leptin/NPY relay[J].Int J Obes(Lond),2020,44(10):2149-2164.
[52] SITAR-TǍUT A V,COZMA A,FODOR A,et al.New insights on the relationship between leptin,ghrelin,and leptin/ghrelin ratio enforced by body mass index in obesity and diabetes[J].Biomedicines,2021,9(11):1657.
[53] TSAY F W,HSU P I.H.pylori infection and extra-gastroduodenal diseases[J].J Biomed Sci,2018,25(1):65.
[54] MURSLEEN M T,RIAZ S.Implication of homocysteine in diabetes and impact of folate and vitamin B12 in diabetic population[J].Diabetes Metab Syndr.2017,11(Suppl 1):S141-S146. |
